Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PH94B for Acute Management of Social Phobia Symptoms
NCT01217788Phase 2Completed
- Sponsor
- Pherin Pharmaceuticals
- Start
- Feb 2008
- Primary completion
- Feb 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Social Anxiety Disorder (SAD) comparing PH94B with Placebo (2 arms). Primary endpoint: Subjective Unit of Discomfort Scale. Started Feb 2008; status: completed.
02
Drugs
fasedienol
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT01217788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01217788.